PharmaTher Holdings Ltd

PharmaTher Holdings Ltd.: A small Canadian pharma firm with high‑volatility stock, investing in innovative drugs and global health solutions despite current losses.

PharmaTher Holdings backs U.S. peptide reclassification, boosting its PharmaPatch™ and PatchPrint™ platforms, while filing patents to stabilize microneedle peptide delivery.

PharmaTher Holdings Ltd.

PharmaTher Holdings Ltd.

PharmaTher Holdings Ltd. is a Canadian pharmaceutical company focused on developing and marketing innovative drugs and healthcare products to improve patient outcomes and quality of life.

PharmaTher Holdings Ltd. is a Canadian pharmaceutical company focused on developing and marketing innovative drugs and healthcare products to improve global health outcomes.

PharmaTher Holdings Ltd. is facing significant challenges, including a delayed FDA review for its ketamine application and financial instability, but its launch of KetaVault, a portal to accelerate ketamine research, offers a glimmer of hope.